245 related articles for article (PubMed ID: 8693434)
1. Age and the treatment of lung cancer.
Brown JS; Eraut D; Trask C; Davison AG
Thorax; 1996 Jun; 51(6):564-8. PubMed ID: 8693434
[TBL] [Abstract][Full Text] [Related]
2. Active treatment rates for lung cancer in south Manchester: are we doing enough?
Devbhandari MP; Joshi V; Barber P; Krysiak P; Shah R; Jones MT
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):411-4. PubMed ID: 20542980
[TBL] [Abstract][Full Text] [Related]
3. Patho-epidemiology of lung cancer in Karachi (1995-2002).
Bhurgri Y; Bhurgri A; Usman A; Sheikh N; Faridi N; Malik J; Ahmed R; Kayani N; Pervez S; Hasan SH
Asian Pac J Cancer Prev; 2006; 7(1):60-4. PubMed ID: 16629517
[TBL] [Abstract][Full Text] [Related]
4. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
5. Gaps in optimal care for lung cancer.
Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
[TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: district active treatment rates affect survival.
Cartman ML; Hatfield AC; Muers MF; Peake MD; Haward RA; Forman D;
J Epidemiol Community Health; 2002 Jun; 56(6):424-9. PubMed ID: 12011196
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.
Means-Markwell M; Linnoila RI; Williams J; Jänne PA; Kaye F; O'Neil K; Johnson BE
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5915-21. PubMed ID: 14676115
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for treatment-related death associated with chemotherapy and thoracic radiotherapy for lung cancer.
Minami-Shimmyo Y; Ohe Y; Yamamoto S; Sumi M; Nokihara H; Horinouchi H; Yamamoto N; Sekine I; Kubota K; Tamura T
J Thorac Oncol; 2012 Jan; 7(1):177-82. PubMed ID: 22134071
[TBL] [Abstract][Full Text] [Related]
11. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit.
Rich AL; Khakwani A; Free CM; Tata LJ; Stanley RA; Peake MD; Hubbard RB; Baldwin DR
QJM; 2015 Nov; 108(11):891-7. PubMed ID: 25725079
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer in individuals less than 50 years of age.
Ak G; Metintas M; Metintas S; Yildirim H; Erginel S; Alatas F
Lung; 2007; 185(5):279-286. PubMed ID: 17705064
[TBL] [Abstract][Full Text] [Related]
15. Age and clinical characteristics of 1433 patients with lung cancer.
Mañé JM; Estapé J; Sánchez-Lloret J; Grau JJ; Palombo H; Agusti C; Mellado B
Age Ageing; 1994 Jan; 23(1):28-31. PubMed ID: 8010167
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
[TBL] [Abstract][Full Text] [Related]
17. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
Berghmans T; Tragas G; Sculier JP
Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer in patients younger than 40 years in a multiracial Asian country.
Liam CK; Lim KH; Wong CM
Respirology; 2000 Dec; 5(4):355-61. PubMed ID: 11192546
[TBL] [Abstract][Full Text] [Related]
19. Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.
Driessen EJ; Aarts MJ; Bootsma GP; van Loon JG; Janssen-Heijnen ML
Lung Cancer; 2017 Jun; 108():198-204. PubMed ID: 28625635
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer in patients aged 50 years and younger: clinical characteristics, treatment details and outcome.
Veness MJ; Delaney G; Berry M
Australas Radiol; 1999 Aug; 43(3):328-33. PubMed ID: 10901928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
